Mins 08040709

8/6/2019 Mins 08040709

1/195

Note: These Minutes are provided for informational purposes only.If you would like to obtain an official copy of the Minutes, please contact

the State Board of Pharmacy at 614-466-4143 for instructions and fee information.

Ohio State Board of Pharmacy 77 South High Street, Room 1702 Columbus, Ohio 43215-6126telephone: 614-466-4143 fax: 614-752-4836 email: [email protected]

Minutes of the April 7-9, 2008

Meeting of the Ohio State Board of Pharmacy

Monday, April 7, 2008

9:07 a.m. The Ohio State Board of Pharmacy convened at the University of Findlay TLB Auditorium,Weinbrenner Theological Seminary, Findlay, Ohio, with the following members present:

Gregory Braylock, R.Ph., President; Elizabeth I. Gregg, R.Ph.; Nathan S. Lipsyc, R.Ph.; KevinJ. Mitchell, R.Ph.; Dorothy S. Teater, Public Member; James E. Turner, R.Ph.; and Jerome J.

Wiesenhahn, R.Ph.

Also present were William T. Winsley, Executive Director; Timothy Benedict, AssistantExecutive Director; William McMillen, Licensing Administrator; Mark Keeley, Legislative AffairsAdministrator; David Rowland, Legal Affairs Administrator; and Sally Ann Steuk, AssistantAttorney General.

The Board members and staff introduced themselves and President Braylock explained thefunction and duties of the Board to the staff and students present from the College of Pharmacyat the University of Findlay.

Mr. McMillen discussed the Licensing Report with the Board.

Mr. Keeley presented the Legislative Report.

10:09 a.m. The Board recessed briefly.

10:21 a.m. The Board was joined by Assistant Attorney General Sally Ann Steuk to conduct anadjudication hearing in accordance with the Ohio Revised Code Chapters 119. and 4729. in thematter of Sarah Elizabeth Lloyd,Intern (06-0-03861), Mason, Ohio.

11:38 a.m. The hearing ended and the record was closed.

Pharmacy Board Compliance Specialist Ann Abele explained a request from PSC MedSupply,LLC, Greensboro, North Carolina, and passed out information for the Board to review.

11:55 a.m. The Board recessed for lunch.

1:05 p.m. The Board reconvened with the following members present:

Gregory Braylock, R.Ph., President; Elizabeth I. Gregg, R.Ph.; Nathan S. Lipsyc, R.Ph.; KevinJ. Mitchell, R.Ph.; Dorothy S. Teater, Public Member; James E. Turner, R.Ph.; and Jerome J.Wiesenhahn, R.Ph.

Because there was a new group of students attending the afternoon session, Board and staffagain introduced themselves and President Braylock discussed the Board's function.

8/6/2019 Mins 08040709

2/195

1:22 p.m. The Board was joined by Assistant Attorney General Sally Ann Steuk to conduct anadjudication hearing in accordance with the Ohio Revised Code Chapters 119. and 4729. in thematter of Lloyd Neal Fisk,R.Ph. (03-2-19476), Grove City, Ohio.

3:28 p.m. The hearing ended and the record was closed.

3:30 p.m. The Board recessed for the day.

Tuesday, April 8, 2008

8:30 a.m. The Ohio State Board of Pharmacy convened in room East B, 31st

Floor, of the Vern RiffeCenter for Government and the Arts, 77 South High Street, Columbus, Ohio, with the followingmembers present:

Nathan S. Lipsyc, R.Ph., Vice-President; Elizabeth I. Gregg, R.Ph.; Kevin J. Mitchell, R.Ph.;Dorothy S. Teater, Public Member; James E. Turner, R.Ph.; and Jerome J. Wiesenhahn,R.Ph.

8:39 a.m. Mrs. Gregg moved that the Board go into Executive Session for the purpose of the investigationof complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Ohio

Revised Code and to confer with an attorney for the Board regarding pending or imminent courtaction pursuant to Section 121.22(G)(3) of the Ohio Revised Code. The motion was secondedby Mr. Wiesenhahn and a roll-call vote was conducted by Vice-President Lipsyc as follows:Gregg yes; Lipsyc yes; Mitchell yes; Teater yes; Turner yes; and Wiesenhahn yes.

9:31 a.m. The Executive Session ended and the meeting was opened to the public.

R-2008-159 After discussion, Mrs. Teater moved that the requestfrom Theodore Perry, R.Ph. (03-2-15670), Cincinnati, Ohio, to withdraw his application for examination as a pharmacist beaccepted. The motion was seconded by Mr. Turner and approved by the Board:Aye 6.

R-2008-160 Subsequently, Mr. Wiesenhahn moved that the Notice of Opportunity for a Hearing issued toMr. Perry be withdrawn. Mrs. Gregg seconded the motion and it was approved by the Board:

Aye 6.

R-2008-161 After discussion, the Board deemed that a request from Mark Alan Bremick, R.Ph. (03-1-20673), Worthington, Ohio, to be allowed to work in a location where there would be no accessto drugs is not a violation of his February 6, 2008, Board Order. Mrs. Gregg moved that therequest be approved. It was seconded by Mr. Wiesenhahn and approved by the Board:Aye 5/Nay - 1.

R-2008-162 The Board deemed that a request from Barney T. Dotson, R.Ph. (03-3-20222), Cincinnati,Ohio, to be allowed to work as a customer service representative in a location where he wouldhave no access to drugs was not a violation of his November 6, 2007, Board Order. Mr.Wiesenhahn moved that the request be approved. The motion was seconded by Mr. Turner

and approved by the Board:Aye 6.

R-2008-163 After discussion, Mr. Turner moved that a proposed Cease and Desist order drafted by Boardstaff be issued in the matter of Vann Healthcare Services, Glasgow Kentucky. The motionwas seconded by Mrs. Gregg and approved by the Board:Aye 6.

R-2008-164 After discussion, Mr. Turner moved that a proposed Cease and Desist order drafted by Boardstaff be issued in the matter of RXBids/Kelvin Bradley, Las Vegas, Nevada. The motion wasseconded by Mr. Lipsyc and approved by the Board:Aye 6.

8/6/2019 Mins 08040709

3/195

R-2008-165 The Board considered a request for an exemption to Ohio Administrative Code Rule 4729-5-10(Prescription pick-up station) received for the following sites:

Teregen Laboratories, Willoughby, Ohio (02-1235150)Various Physician Offices on the letter of request

After discussion, Mrs. Gregg moved that the Board approve the request as long as the partiesto the request comply with the requirements in the rule for such an exemption. The motion was

seconded by Mr. Turner and approved by the Board:Aye 6.

R-2008-166 Mrs. Gregg moved that Board staff be authorized to approve requests for exceptions from therequirements of OAC 4729-5-10 Pickup Stations in those cases involving the delivery ofchemotherapeuticagents to prescribers offices for direct administration of the drugs. Themotion was seconded by Mrs. Teater and approved by the Board:Aye 6.

Mrs. Droz discussed the Prescription Drug Monitoring Program with the Board.

R-2008-167 Mr. McMillen presented a request from pharmacy intern Maria Vladimirovna Wolf (06-0-06884), Marrow, Ohio, for permission to extend her internship one additional year due toextraordinary circumstances pursuant to Rule 4729-3-04 (Pharmacy Intern Identification CardRenewal). After discussion, Mr. Turner moved that the request be approved. The motion was

seconded by Mrs. Teater and approved by the Board:Aye 6.

Mr. Keeley gave an additional brief review of the Legislative Report.

10:21 a.m. The Board recessed briefly.

10:29 a.m. Mrs. Gregg moved that the Board go into Executive Session for the purpose of the investigationof complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the OhioRevised Code. The motion was seconded by Mr. Mitchell and a roll-call vote was conducted byVice-President Lipsyc as follows: Gregg yes; Lipsyc yes; Mitchell yes; Turner yes; Teater

yes; and Wiesenhahn yes.

10:44 a.m. President Braylock arrived and joined the Executive Session in progress.


R-2008-168 Mrs. Gregg moved that the following order be adopted in the matter of Sarah Elizabeth Lloyd,Intern (06-0-03861), Mason, Ohio.

ORDER OF THE STATE BOARD OF PHARMACYDocket Number D-080212-037

in the matter of:

SARAH ELIZABETH LLOYD

6868 Rosetree PlaceMason, Ohio 45040

INTRODUCTION

The matter of Sarah Elizabeth Lloyd came for hearing on April 7, 2008, beforethe following members of the Board: Gregory Braylock, R.Ph. (presiding);Elizabeth I. Gregg, R.Ph.; Nathan S. Lipsyc, R.Ph.; Kevin J. Mitchell, R.Ph.;Dorothy S. Teater, Public Member; James E. Turner, R.Ph.; and Jerome J.Wiesenhahn, R.Ph.

8/6/2019 Mins 08040709

4/195

Sarah Elizabeth Lloyd was not represented by counsel. The State of Ohio wasrepresented by Sally Ann Steuk, Assistant Attorney General.

SUMMARY OF EVIDENCE

States Witnesses: Ann Abele, R.Ph., Ohio State Board of PharmacySarah Elizabeth Lloyd, Respondent

Respondent's Witnesses: None

State's Exhibits:

1. Proposal to Deny/Notice of Opportunity for Hearing letter [02-12-08]1A-1D. Procedurals2. Application for Pharmacy Intern Registration Submitted by Sarah Elizabeth

Lloyd [01-08-08]3. Skilled Care Pharmacy Application for Employment for Sarah E. Gray [07-

15-05]4. Ohio State Board of Pharmacy Application for Renewal of a Pharmacy

Intern Identification Card for Sarah Elizabeth Lloyd [08-12-05]5. Offer of Employment letter from Skilled Care Pharmacy to Sarah Gray [07-

26-05]6. Skilled Care Pharmacy Position Description for Pharmacy Intern [08-25-

05]7. Notarized Statement of Angela Sagraves, R.Ph. [04-26-07]8. Notarized Statement of Vickie Haury [05-01-07]9. Notarized Statement of Sarah Lloyd [05-01-07]10. Skilled Care Time & Attendance - Summary Report for Sarah Gray [09-16-

06 to 05-17-07]11. Facsimile Letter from Michael Burleson, R.Ph., Kentucky Board of

Pharmacy [05-03-07]

Respondent's Exhibits:

A. Two Letters of Support [04-07-08]

FINDINGS OF FACT

After having heard the testimony, observed the demeanor of the witnesses,considered the evidence, and weighed the credibility of each, the State Board ofPharmacy finds the following to be fact:

(1) Records of the State Board of Pharmacy indicate that Sarah ElizabethLloyd submitted an Application For Examination As A Pharmacist on orabout January 8, 2008.

(2) Records further indicate that Sarah Elizabeth Lloyd was originally licensed

as a pharmacy intern in Ohio on June 20, 2002 and that her license (06-0-03861) to practice as an intern lapsed September 15, 2006.

(3) Sarah Elizabeth Lloyd did, from September 16, 2006, through April 19,2007, while not a pharmacist or pharmacy intern, dispense drugs and/orotherwise engage in the practice of pharmacy, to wit: after allowing herintern license to lapse, Sarah Elizabeth Lloyd lied to her employer, SkilledCare Pharmacy, about her examination status, and Sarah Elizabeth Lloydcontinued to practice pharmacy as a registered intern. Such conduct is inviolation of Section 4729.28 of the Ohio Revised Code.

8/6/2019 Mins 08040709

5/195

(4) Sarah Elizabeth Lloyd did, on or about July, 2005, while being a registeredpharmacy intern, fail to notify the Board of her change in her mailingaddress within 30 days of the effective date, to wit: after getting marriedand moving, on two different occasions, Sarah Elizabeth Lloyd did notnotify the Board of the changes. Such conduct is in violation of Rule 4729-5-06(A) of the Ohio Administrative Code.

(5) Sarah Elizabeth Lloyd did, on or about August, 2005, while being a

registered pharmacy intern, fail to notify the Board of her change in herplace of employment within 30 days of the effective date, to wit: afterchanging employment from Kroger Pharmacy to Skilled Care Pharmacy onJuly 8, 2005, Sarah Elizabeth Lloyd did not notify the Board of the change.Such conduct is in violation of Rule 4729-5-06(B) of the OhioAdministrative Code.

CONCLUSIONS OF LAW

(1) The State Board of Pharmacy concludes that paragraph (3) of the Findingsof Fact constitutes not being of good moral character and habits asprovided in paragraph (C) of Rule 4729-5-04 of the Ohio AdministrativeCode.

(2) The State Board of Pharmacy concludes that paragraphs (3) through (5) ofthe Findings of Fact constitute being guilty of dishonesty andunprofessional conduct in the practice of pharmacy as provided in Division(A)(2) of Section 4729.16 of the Ohio Revised Code.

(3) The State Board of Pharmacy concludes that paragraphs (3) through (5) ofthe Findings of Fact constitute being guilty of willfully violating, conspiringto violate, attempting to violate, or aiding and abetting the violation ofprovisions of Chapter 4729. of the Revised Code as provided in Division(A)(5) of Section 4729.16 of the Ohio Revised Code.

DECISION OF THE BOARD

Pursuant to Section 4729.16 of the Ohio Revised Code, and after considerationof the record as a whole, the State Board of Pharmacy hereby approves theApplication For Examination As A Pharmacist submitted by Sarah ElizabethLloyd; however, she may not sit for the examinations before July 1, 2008.

Mr. Turner seconded the motion and it was approve by the Board:Aye 6.

R-2008-169 Mr. Turner moved that the following order be adopted in the matter of Lloyd Neal Fisk,R.Ph.(03-2-19476), Grove City, Ohio.

ORDER OF THE STATE BOARD OF PHARMACY

Docket Number D-070910-008

in the matter of:

LLOYD NEAL FISK, R.Ph.3553 Lake Mead DriveGrove City, Ohio 43123

R.Ph. Number 03-2-19476

8/6/2019 Mins 08040709

6/195

INTRODUCTION

The matter of Lloyd Neal Fisk came for hearing on April 7, 2008, before thefollowing members of the Board: Gregory Braylock, R.Ph. (presiding); Elizabeth I.Gregg, R.Ph.; Nathan S. Lipsyc, R.Ph.; Kevin J. Mitchell, R.Ph.; Dorothy S.Teater, Public Member; James E. Turner, R.Ph.; and Jerome J. Wiesenhahn,R.Ph.

Lloyd Neal Fisk was represented by Daniel D. Connor. The State of Ohio wasrepresented by Sally Ann Steuk, Assistant Attorney General.

SUMMARY OF EVIDENCE

States Witness: John Whittington, D.O., R.Ph.Ohio State Board of Pharmacy

Respondent's Witnesses: Lloyd Neal Fisk, R.Ph., RespondentSuzanne Fisk

State's Exhibits:

1. Summary Suspension Order/Notice of Opportunity For Hearing letter [09-10-07]

1A-1D. Procedurals2. Four black and white photographs [not dated]3. Three color photographs [08-17-07]4. Review Send Report of Childrens Hospital [01-01-06 to 08-30-07]5. Notarized Statement of Julie Zaucha, R.Ph. [03-18-08]6. Job Description for Information Services Pharmacist at Children's Hospital,

Inc. [not dated]7. Notarized Statement of Lloyd Fisk [08-30-07]8. Six photocopies of drugs [not dated]9. Signed receipt for Controlled Substances [08-30-07]10. Indictment, State of Ohio vs. Lloyd Fisk, Case No. 07CR 10-7800, Franklin

County Common Pleas Court [10-26-07]; Entry of Guilty Plea [02-26-08]


A. PRO Pharmacists Recovery Contract for Lloyd Neal Fisk [10-16-07]B. Pinnacle Behavioral Health Medical Records [05-16-07]C. Medical Records of Lloyd N. Fisk [11-22-99 to 08-17-07]; Letter from

Daniel D. Connor to Francisco C. Buendia Jr. [09-26-07]; Authorization toDisclose Health Information [09-20-07]

D. The Ohio State University Medical Records [08-30-07]E. Letter from Benjamin P. Kelch to Daniel D. Conner (sic) [02-08-08]F. The Woods at Parkside Medical Records [08-30-07 to 11-05-07]G. Drug Screen Reports [11-28-07 to 03-18-08]; Drug Testing Panels [10-11-

06]H. Support Group Attendance Records [09-11-07 to 03-15-08]I. Six Letters of Support [03-16-08 to 03-31-08]J. Restitution Documentation Letter [04-01-08]

FINDINGS OF FACT


8/6/2019 Mins 08040709

7/195

(1) Records of the Board of Pharmacy indicate that Lloyd Neal Fisk wasoriginally licensed by the State of Ohio as a pharmacist on July 30, 1992,pursuant to examination, and that his license to practice pharmacy in Ohiowas summarily suspended effective September 10, 2007.

(2) Lloyd Neal Fisk is addicted to the use of controlled substances, to wit:Lloyd Neal Fisk has admitted to Board agents that he is and has beenaddicted to oxycodone for some time now. Lloyd Neal Fisk has

admittedly stolen drugs from his employer, Columbus Childrens Hospital,and consumed oxycodone as often as four to six times per day whilepracticing pharmacy. Such conduct indicates that Lloyd Neal Fisk is withinthe ambit of Sections 3719.121 and/or 4729.16(A)(3) of the Ohio RevisedCode.

(3) Lloyd Neal Fisk did, from January 30, 2007, through August 28, 2007, withpurpose to deprive, knowingly obtain or exert control over dangerousdrugs, the property of Columbus Childrens Hospital, by deception, to wit:Lloyd Neal Fisk has admittedly created false computer records so as tosteal oxycodone tablets from the hospitals PyxisCII safe. On at least 40different occasions, Lloyd Neal Fisk surreptitiously entered the computer tosteal a total of 3,710 oxycodone tablets. Such conduct is in violation of

Section 2913.02 of the Ohio Revised Code.

(4) Lloyd Neal Fisk did, from January 30, 2007, through August 28, 2007,knowingly gain access to a computer and/or computer system beyond thescope of the express or implied consent of the owner of the system orperson authorized to give consent, to wit: Lloyd Neal Fisk admittedly usedhis position as the Information Services Pharmacist at ColumbusChildrens Hospital to set up an account using anothers name and LloydNeal Fisk's ring finger (for positive ID purposes) so Lloyd Neal Fisk couldsteal oxycodone without detection. Such conduct is in violation of Section2913.04(B) of the Ohio Revised Code.

CONCLUSIONS OF LAW

(1) The State Board of Pharmacy concludes that paragraphs (3) and (4) of theFindings of Fact constitute being guilty of a felony and gross immorality asprovided in Division (A)(1) of Section 4729.16 of the Ohio Revised Code.

(2) The State Board of Pharmacy concludes that paragraphs (3) and (4) of theFindings of Fact constitute being guilty of dishonesty and unprofessionalconduct in the practice of pharmacy as provided in Division (A)(2) ofSection 4729.16 of the Ohio Revised Code.

(3) The State Board of Pharmacy concludes that paragraph (2) of the Findingsof Fact constitutes being addicted to or abusing liquor or drugs or impaired

physically or mentally to such a degree as to render him unfit to practicepharmacy as provided in Division (A)(3) of Section 4729.16 of the OhioRevised Code.

DECISION OF THE BOARD

Pursuant to Section 3719.121 of the Ohio Revised Code, the State Board ofPharmacy hereby removes the Summary Suspension Order issued to Lloyd NealFisk on September 10, 2007.

8/6/2019 Mins 08040709

8/195

Pursuant to Section 4729.16 of the Ohio Revised Code, and after considerationof the record as a whole, the State Board of Pharmacy hereby suspendsindefinitely the pharmacist identification card, No. 03-2-19476, held by Lloyd NealFisk and such suspension is effective as of the date of the mailing of this Order.

(A) Lloyd Neal Fisk, pursuant to Rule 4729-9-01(F) of the Ohio AdministrativeCode, may not be employed by or work in a facility licensed by the StateBoard of Pharmacy to possess or distribute dangerous drugs during such

period of suspension.

(B) Lloyd Neal Fisk, pursuant to Section 4729.16(B) of the Ohio Revised Code,must return his identification card and license (wall certificate) to the officeof the State Board of Pharmacy within ten days after receipt of this Orderunless the Board office is already in possession of both. The identificationcard and wall certificate should be sent by certified mail, return receiptrequested.

Further, after one year from the effective date of this Order, the Board willconsider any petition filed by Lloyd Neal Fisk for a hearing, pursuant to OhioRevised Code Chapter 119., for reinstatement. The Board will only considerreinstatement of the license to practice pharmacy in Ohio if the following

conditions have been met:

(A) Lloyd Neal Fisk must enter into a new contract, signed within thirty daysafter the effective date of this Order, with an Ohio Department of Alcoholand Drug Addiction Services (ODADAS) treatment provider or a treatmentprovider acceptable to the Board for a period of not less than five yearsand submit a copy of the signed contract to the Board office. The contractmust provide that:

(1) Random, observed urine drug screens shall be conducted at leastonce each month.

(a) The urine sample must be given within twelve hours ofnotification. The urine drug screen must include testing forcreatinine or specific gravity of the sample as the dilutionalstandard.

(b) Results of all drug screens must be negative. Refusal of adrug screen or a diluted drug screen is equivalent to a positiveresult. Any positive results, including those which may haveresulted from ingestion of food, but excluding false positiveswhich resulted from medication legitimately prescribed,indicates a violation of the contract.

(2) The intervener/sponsor shall submit reports to the Board, in a format

acceptable to the Board, indicating drug screens and their results ina timely fashion. Actual copies of drug screens shall be madeavailable to the Board upon request.

(3) Attendance is required a minimum of three times per week at anAlcoholics Anonymous, Narcotics Anonymous, and/or similar supportgroup meeting.

(4) The program shall immediately report to the Board any violations ofthe contract and/or lack of cooperation.

8/6/2019 Mins 08040709

9/195

(B) Lloyd Neal Fisk must demonstrate satisfactory proof to the Board that he isno longer addicted to or abusing drugs or impaired physically or mentally tosuch a degree as to render him unfit to practice pharmacy.

(C) Lloyd Neal Fisk must provide, at the reinstatement petition hearing,documentation of the following:

(1) Compliance with the contract required above (e.g.-proof of giving the

sample within twelve hours of notification and copies of all drugscreen reports, meeting attendance records, treatment programreports, etc.);

(2) Compliance with the continuing pharmacy education requirementsset forth in Chapter 4729-7 of the Ohio Administrative Code asapplicable and in effect on the date of petitioning the Board forreinstatement;

(3) Compliance with the terms of this Order.

(D) If reinstatement is not accomplished within three years of the effective dateof this Order, Lloyd Neal Fisk must also show successful completion of the

North American Pharmacist Licensure Examination (NAPLEX)examination.

(E) Upon such time as the Board may consider reinstatement, Lloyd Neal Fiskwill be afforded a Chapter 119. hearing. At such time, the Board mayconsider reinstatement with or without restrictions and/or conditions as theBoard deems appropriate under the circumstances.

Mr. Wiesenhahn seconded the motion and it was approved by the Board:Aye 6.

Lorraine Marie Kaup, R.Ph. (03-1-13596), of Kaup Pharmacy Inc., met with the Board torequest a change in the use of the Parata electronic prescribing system, approved December3, 2007, to include after-hours use in a new pharmacy in Arcanum, Ohio. After discussing herproposal with her, Mr. Braylock thanked her for meeting with the Board and said that the Boardwould reach a decision during the meeting and then notify her of the result.

11:51 a.m. Mr. Mitchell said the Medical Board Physician Assistant Policy Committee did not meet thismonth.

Mr. Braylock said the Nursing Board Committee on Prescriptive Governance meeting wascancelled this month.

Mr. Benedict did not have a Medical Board Prescribing Committee report for this month.

11:54 a.m.

R-2008-170 Mr. Keeley discussed a request from workflow.com, Westlake, Ohio, concerning its electronicprescribing system. After discussion, Mr. Lipsyc moved that the system be found approvablepending final inspection. Mr. Turner seconded the motion and it was approved by the Board:

Aye 6.

12:03 p.m. The Board recessed for lunch.

1:16 p.m. The Board reconvened in room East B, 31st

Floor, of the Vern Riffe Center for Government andthe Arts, 77 South High Street, Columbus, Ohio, with the following members present:

8/6/2019 Mins 08040709

10/195

Gregory Braylock, R.Ph., President; Nathan S. Lipsyc, R.Ph., Vice-President; Elizabeth I. Gregg,R.Ph.; Kevin J. Mitchell, R.Ph.; Heather L. Pasquale, R.Ph.; Dorothy S. Teater, Public Member;James E. Turner, R.Ph.; and Jerome J. Wiesenhahn, R.Ph.

Pharmacy Board Compliance Specialist Joann Predina discussed the Rescue-Data collectionsystem for emergency medical services with the Board.

1:30 p.m.

R-2008-171 The following candidates for licensure by reciprocity met with the Board members in RoomSouth A, 31

stFloor, of the Vern Riffe Center, Columbus, Ohio, the candidates and the Board

members introduced themselves and the candidates then participated in a discussion ofpharmacy laws and rules with Mr. McMillen. They were then presented their pharmacistidentification cards.

Scott W. Amstutz 03-2-28515 IndianaRobin Lee Burris 03-2-28438 MissouriHarold Douglas Certain 03-2-28534 KentuckyAmanda Lea Coats 03-2-28516 KentuckyKenneth Richard Einhorn 03-2-28490 New JerseyGeorge Eid Aziz Megaly 03-2-28488 New JerseyVictoria Lynn Patterson 03-2-28355 Michigan

Christopher John Thompson 03-2-28527 Wisconsin

2:01 p.m. The Board was joined by Assistant Attorney General Sally Ann Steuk to conduct anadjudication hearing in accordance with the Ohio Revised Code Chapters 119. and 4729. in thematter of Steven Joseph Holtel,R.Ph. (03-1-13701), Nelsonville, Ohio.

5:21 p.m. The hearing ended and the record was closed.

The Board recessed for the day.

Wednesday, April 9,2008

8:30a.m. The Ohio State Board of Pharmacy convened in room East B, 31st Floor, of the Vern RiffeCenter for Government and the Arts, 77 South High Street, Columbus, Ohio, with the followingmembers present:

Nathan S. Lipsyc, R.Ph., Vice-President; Elizabeth I. Gregg, R.Ph.; Richard F. Kolezynski,R.Ph.; Kevin J. Mitchell, R.Ph.; Heather L. Pasquale, R.Ph.; James E. Turner, R.Ph.; andJerome J. Wiesenhahn, R.Ph.

R-2008-172 After discussion, Mr. Kolezynski moved that the conference call Board minutes of March 19,2008, be approved as presented. Mr. Lipsyc seconded the motion and it was approved by theBoard:Aye 7.

8:31 a.m. President Braylock and Mrs. Teater arrived and joined the meeting in progress.

R-2008-173 After discussion, Mr. Lipsyc moved that the conference call Board minutes of March 25, 2008,be approved as presented. Ms. Pasquale seconded the motion and it was approved by the

Board:Aye 8.

R-2008-174 After discussion, Mrs. Gregg moved that the Board minutes of March 3-5, 2008 be approved asamended. Mr. Wiesenhahn seconded the motion and it was approved by the Board:Aye 8.

8:47 a.m. Mrs. Gregg moved that the Board go into Executive Session for the purpose of the investigationof complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Ohio

8/6/2019 Mins 08040709

11/195

Revised Code. The motion was seconded by Mr. Turner and a roll-call vote was conducted byPresident Braylock as follows: Gregg yes; Lipsyc yes; Kolezynski yes;Mitchell yes;Pasquale yes; Turner yes; Teater yes; and Wiesenhahn yes.


R-2008-175 Mrs. Gregg moved that the following order be adopted in the matter of Steven Joseph Holtel ,R.Ph. (03-1-13701), Nelsonville, Ohio.

ORDER OF THE STATE BOARD OF PHARMACYDocket Number D-071115-015

in the matter of:

STEVEN HOLTEL, R.Ph.40 Watkins Street

Nelsonville, Ohio 45764

R.Ph. Number 03-1-13701

INTRODUCTION

The matter of Steven Holtel came for hearing on April 8, 2008, before thefollowing members of the Board: Gregory Braylock, R.Ph. (presiding); Elizabeth I.Gregg, R.Ph.; Nathan S. Lipsyc, R.Ph.; Kevin J. Mitchell, R.Ph.; Heather L.Pasquale, R.Ph.; Dorothy S. Teater, Public Member; James E. Turner, R.Ph.;and Jerome J. Wiesenhahn, R.Ph.

Steven Holtel was represented by Herman A. Carson. The State of Ohio wasrepresented by Sally Ann Steuk, Assistant Attorney General.

SUMMARY OF EVIDENCE

States Witness: William L. Padgett, Ohio State Board of Pharmacy

Respondent's Witness: Steven Holtel, R.Ph., Respondent

State's Exhibits:

1. Notice of Opportunity For Hearing letter [11-15-07]1A-1F. Procedurals2. One prescription for alprazolam 0.25 mg3. Twenty-three prescriptions for alprazolam 0.5 mg4. Eighty-one prescriptions for alprazolam 1 mg5. Two hundred nineteen prescriptions for alprazolam 2 mg6. Twenty-nine prescriptions for Ambien 10 mg

7. Twenty-three prescriptions for APAP/codeine 300/30 mg8. Fifty prescriptions for butalbital/aspirin/caffeine/codeine 30 mg9. Nine prescriptions for clonazepam 2 mg10. One hundred seventy-nine prescriptions for diazepam 10 mg11. Twenty-three prescriptions for diazepam 5 mg12. Two prescriptions for diazepam 5 mg/ml13. Four prescriptions for Fioricet/codeine 30 mg14. Ninety-eight prescriptions for hydrocodone/ibuprofen 7.5/200 mg15. Three thousand one hundred sixty-two prescriptions for

hydrocodone/ibuprofen 10/325 mg

8/6/2019 Mins 08040709

12/195

16. One thousand seven hundred ninety-one prescriptions for hydrocodone/APAP 10/500 mg

17. Five hundred fifty-two prescriptions for hydrocodone/APAP 10/650 mg18. One prescription for hydrocodone/APAP 10/660 mg19. One thousand seven hundred ninety-two prescriptions for

hydrocodone/APAP 5/500 mg20. Six hundred seventeen prescriptions for hydrocodone/APAP 7.5/500 mg21. Seven hundred fourteen prescriptions for hydrocodone/APAP 7.5/750 mg

22. Two prescriptions for hydrocodone compound syrup 5mg/5ml23. Six prescriptions for Hydromet syrup 5mg/5ml24. One prescription for Klonopin 2mg25. One prescription for Klonopin 1mg26. Two prescriptions for Lomotil 2.5 mg/5ml27. Two prescriptions for lorazepam 0.5 mg28. Seven prescriptions for lorazepam 1 mg29. Six prescriptions for lorazepam 2 mg30. Four prescriptions for Lorcet 10/350 mg31. Twenty-four prescriptions for Lortab 10/500 mg32. Two prescriptions for Lortab 5/500 mg33. Six prescriptions for Lortab 7.5/500 mg34. No Exhibit

35. Fourteen prescriptions for Norco 10/325 mg36. One prescription for Pentazocine/APAP 25/650 mg37. Two prescriptions for pentazocine/naloxone 50 mg38. Two prescriptions for phenobarbital 64.8 mg39. Fifty-six prescriptions for propoxyphene N/APAP 100/650 mg40. Four prescriptions for temazepam 30 mg41. Two prescriptions for triazolam 0.25 mg42. One prescription for Valium 10 mg43. One prescription for Vicodin 5/500 mg44. Two hundred ten prescriptions for Vicodin ES 7.5/750 mg45. Eight prescriptions for Vicoprofen 7.5/200 mg46. One prescription for Xanax 1 mg47. One prescription for Xanax 2 mg48. One prescription for acyclovir 800 mg49. Two prescriptions for butalbital/APAP/caffeine 50/325/40 mg50. Two hundred twenty-two prescriptions for carisoprodol 350 mg51. Fourteen prescriptions for cyclobenzaprine 10 mg52. Four prescriptions for methocarbamol 750 mg53. One prescription for naproxen 500 mg54. Five prescriptions for promethazine 25 mg55. One prescription for Strattera 40 mg56. Seven prescriptions for tramadol 50 mg57. Eight prescriptions for Tussionex 10 mg/5ml58. Copy of Internet Web page for Doctor Scripts (Online Scripts), www.doctor-

scripts.com/index.php [12-20-05]

59. Internet Prescription Summary [10-17-05 to 02-14-06]60. No Exhibit61. Professional Services Agreement between Internet Health Enterprises,

L.L.C. and Stoltz Drugs, Inc. [12-16-05]62. Facsimile from Rick to Dr. Ibanez & All Doctors [not dated]; Ohio State

Board of Pharmacy News, February 2005; Copy of Steve Holtel's BusinessCard [not dated]

63. Facsimile from Rick Shipp, Internet Health Enterprises to Steve Holtel [notdated]; Copy of Florida Revised Code 64B8-9.014 defining "Standards forTelemedicine Prescribing Practice" [09-14-03]

8/6/2019 Mins 08040709

13/195

64. Facsimile from Rick Shipp to Steve [10-13-05]; Copy of OhioAdministrative Code (OAC) Rule 4729-05-22 defining "Patient Counseling"[02-01-98]

65. List of Internet Prescribers for Stolz Pharmacy [not dated]66. Service Request Detail 1-2416251969 for Stoltz Drug [04-30-07]67. Twelve examples of Internet prescriptions filled by Stoltz Pharmacy68. Stoltz Drug Store Inc. Carrier Audit Detail [10-01-05 to 02-28-06]69. Lawriter OAC Rule 4729-5-30 defining "Manner of Issuance of a

Prescription" [10-19-07]70. Lawriter OAC Rule 4729-5-21 defining "Manner of Processing a

Prescription" [04-27-07]71. Exhibit List for Stoltz Leader Drug and R.Ph Steve Holtel [not dated]72. Copy of a Map of the United States displaying Internet Prescribers

Locations; Map displaying Patients locations [not dated]


A. Facsimile of e-Connect (Pharmacists' Online Information Resource)Newswire OIG Report titled "Pharmacists' Profits on Medicare Part DRazor Thin" [January 2008]

B. Letter from Joseph T. Rannazzisi to Stoltz Leader Drug [08-13-07]

C. Letter from Andrea L. Smith to Herman A. Carson [03-21-08]D. Letter from Robert E. O'Neill to Herman A. Carson [04-04-08]E-I. Five Letters of Support [03-19-08 to 03-28-08]

FINDINGS OF FACT


(1) Records of the State Board of Pharmacy indicate that Steven Holtel wasoriginally licensed by the State of Ohio as a pharmacist on December 2,1980, pursuant to reciprocity, and is currently licensed to practice

pharmacy in Ohio. Records further reflect during the relevant time periodsstated herein, Steven Holtel was the Responsible Pharmacist at StoltzLeader Drug, 40 Watkins Street, Nelsonville, Ohio, pursuant to Sections4729.27 and 4729.55 of the Ohio Revised Code and Rule 4729-5-11 of theOhio Administrative Code.

(2) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: alprazolam 0.25 mg.

Date filled Script # Drug StrengthQtyDisp

PtState

PresState RPh

11/19/05 1019701 alprazolam 0.25 mg 10 IA FL SH

Such conduct is in violation of Section 2925.03 of the Ohio Revised Code.

(3) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the following

8/6/2019 Mins 08040709

14/195

8/6/2019 Mins 08040709

15/195

Date filled Script# Drug StrengthQtyDisp

PtState

PresState RPh

11/17/05 1019113 alprazolam 1 mg 90 GA FL SH

11/17/05 1019332 alprazolam 1 mg 90 TN FL SH

11/18/05 1019630 alprazolam 1 mg 90 GA GA SH

11/18/05 1019383 alprazolam 1 mg 90 WA GA SH

11/21/05 1019989 alprazolam 1 mg 60 OH FL SH

11/22/05 1020318 alprazolam 1 mg 90 FL GA SH

11/25/05 1020952 alprazolam 1 mg 30 AL GA SH

11/25/05 1020923 alprazolam 1 mg 60 CA FL SH

11/25/05 1020858 alprazolam 1 mg 60 LA FL SH

11/26/05 1021118 alprazolam 1 mg 90 MS GA SH

11/26/05 1021178 alprazolam 1 mg 90 PA GA SH

11/29/05 1021963 alprazolam 1 mg 90 OH OH SH

11/29/05 1021941 alprazolam 1 mg 60 TX FL SH

11/30/05 1022054 alprazolam 1 mg 60 AR FL SH


12/06/05 1023098 alprazolam 1 mg 90 NC GA SH

12/12/05 1023989 alprazolam 1 mg 60 AL FL SH

12/13/05 1024347 alprazolam 1 mg 90 AL FL MBH


12/16/05 1025106 alprazolam 1 mg 60 MN OH SH



12/22/05 1026562 alprazolam 1 mg 60 LA OH SH




12/29/05 1027884 alprazolam 1 mg 60 NC FL SH



01/07/06 1029579 alprazolam 1 mg 60 GA OH SH

01/07/06 1029643 alprazolam 1 mg 30 MN FL SH

01/07/06 1029641 alprazolam 1 mg 60 WA FL SH

01/09/06 1030003 alprazolam 1 mg 60 HI FL SH

01/09/06 1030129 alprazolam 1 mg 60 IL FL SH

01/09/06 1030124 alprazolam 1 mg 60 TN OH SH

01/10/06 1030412 alprazolam 1 mg 60 OR FL SH

01/11/06 1030780 alprazolam 1 mg 30 FL FL SH


01/12/06 1031070 alprazolam 1 mg 60 IN FL SH

01/13/06 1031277 alprazolam 1 mg 90 UT FL SH

01/19/06 1032695 alprazolam 1 mg 60 TN GA SH







01/27/06 1034272 alprazolam 1 mg 60 WV FL SH


02/01/06 1035294 alprazolam 1 mg 90 NJ OH SH


02/03/06 1035975 alprazolam 1 mg 30 CA FL BB

8/6/2019 Mins 08040709

16/195


PtState

PresState RPh

02/03/06 1035989 alprazolam 1 mg 30 CA OH BB

02/03/06 1035907 alprazolam 1 mg 30 VA FL BB






02/10/06 1037755 alprazolam 1 mg 60 CT FL SH

02/10/06 1037737 alprazolam 1 mg 30 MN FL SH

02/10/06 1037828 alprazolam 1 mg 90 MS FL SH




(5) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the Ohio

Revised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: alprazolam 2 mg.


PtState

PresState RPh



10/20/05 1013417 alprazolam 2 mg 30 AZ GA SH

10/20/05 1013264 alprazolam 2 mg 60 MA FL SH



10/20/05 1013228 alprazolam 2 mg 90 TN FL SH10/24/05 1013989 alprazolam 2 mg 90 NULL FL SH

10/26/05 1014468 alprazolam 2 mg 90 PA OH SH







11/01/05 1015695 alprazolam 2 mg 60 FL OH SH


11/01/05 1015686 alprazolam 2 mg 30 TX OH SH

11/01/05 1015653 alprazolam 2 mg 90 WV FL SH11/02/05 1015844 alprazolam 2 mg 60 IL OH SH









11/07/05 1016689 alprazolam 2 mg 90 AR OH SH

8/6/2019 Mins 08040709

17/195


PtState

PresState RPh






11/08/05 1017128 alprazolam 2 mg 90 NE FL SH


11/08/05 1017063 alprazolam 2 mg 90 WV OH SH

11/09/05 1017405 alprazolam 2 mg 90 GA GA SH


11/09/05 1017449 alprazolam 2 mg 90 NY FL SH




11/10/05 1017741 alprazolam 2 mg 60 ID FL SH


11/10/05 1017650 alprazolam 2 mg 60 SC FL SH



11/12/05 1018159 alprazolam 2 mg 30 AZ FL SH



11/14/05 1018401 alprazolam 2 mg 60 WV OH SH

11/15/05 1018590 alprazolam 2 mg 60 CO FL SH




11/15/05 1018629 alprazolam 2 mg 90 PA FL SH

11/16/05 1019007 alprazolam 2 mg 60 FL GA SH

11/16/05 1018874 alprazolam 2 mg 60 MA FL SH






11/18/05 1019519 alprazolam 2 mg 60 UT OH MBH



11/19/05 1019715 alprazolam 2 mg 60 OH GA SH







11/25/05 1020881 alprazolam 2 mg 60 LA GA SH

11/26/05 1021115 alprazolam 2 mg 30 ID OH SH




11/29/05 1021833 alprazolam 2 mg 90 FL OH MBH


8/6/2019 Mins 08040709

18/195


PtState

PresState RPh

11/29/05 1021829 alprazolam 2 mg 90 OH OH MBH



12/06/05 1023159 alprazolam 2 mg 60 CA GA SH




12/06/05 1022990 alprazolam 2 mg 60 TX FL MBH

12/07/05 1023350 alprazolam 2 mg 90 FL FL MBH





12/13/05 1024456 alprazolam 2 mg 60 WI OH SH



12/16/05 1025123 alprazolam 2 mg 60 AL OH SH


12/16/05 1025150 alprazolam 2 mg 90 SC OH SH





12/21/05 1026249 alprazolam 2 mg 90 MD FL SH





12/23/05 1026942 alprazolam 2 mg 79 IN GA SH






12/28/05 1027415 alprazolam 2 mg 30 IN GA SH



12/30/05 1028173 alprazolam 2 mg 60 WV GA SH






01/07/06 1029575 alprazolam 2 mg 60 MI FL SH


01/09/06 1030075 alprazolam 2 mg 90 IA FL SH







8/6/2019 Mins 08040709

19/195

8/6/2019 Mins 08040709

20/195


PtState

PresState RPh










02/08/06 1037170 alprazolam 2 mg 90 OK OH SH














02/10/06 1037937 alprazolam 2 mg 90 NC GA SH

02/10/06 1037942 alprazolam 2 mg 90 PA OH SH





02/11/06 1038122 alprazolam 2 mg 60 MA GA SH



02/13/06 1038487 alprazolam 2 mg 90 WV FL BB


(6) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: Ambien 10 mg.


PtState

PresState RPh

10/26/05 1014281 Ambien 10 mg 30 CA FL SH

10/31/05 1015255 Ambien 10 mg 30 TX GA SH

11/04/05 1016238 Ambien 10 mg 30 CA GA SH

11/10/05 1017747 Ambien 10 mg 30 NY GA SH

11/12/05 1018154 Ambien 10 mg 30 MD OH SH

11/16/05 1018806 Ambien 10 mg 30 NJ FL SH

11/16/05 1018816 Ambien 10 mg 30 TN FL SH

12/07/05 1023298 Ambien 10 mg 30 MN GA SH

8/6/2019 Mins 08040709

21/195


PtState

PresState RPh

12/13/05 1024463 Ambien 10 mg 30 CO OH SH

12/20/05 1025822 Ambien 10 mg 30 GA FL SH

12/22/05 1026600 Ambien 10 mg 30 CA GA SH

01/05/06 1029047 Ambien 10 mg 30 FL FL SH

01/07/06 1029645 Ambien 10 mg 30 FL FL SH

01/07/06 1029587 Ambien 10 mg 30 OH FL SH

01/09/06 1030115 Ambien 10 mg 30 CA GA SH

01/14/06 1031584 Ambien 10 mg 30 MD OH SH

01/18/06 1032490 Ambien 10 mg 30 GA FL SH

01/19/06 1032702 Ambien 10 mg 30 IL FL SH

01/19/06 1032761 Ambien 10 mg 30 NY OH SH

01/25/06 1033781 Ambien 10 mg 30 AZ FL SH

01/30/06 1034542 Ambien 10 mg 30 CT OH SH

02/03/06 1035984 Ambien 10 mg 30 PA OH BB

02/07/06 1036869 Ambien 10 mg 30 FL FL SH

02/09/06 1037372 Ambien 10 mg 30 CO OH SH

02/09/06 1037395 Ambien 10 mg 30 NY GA SH

02/10/06 1037741 Ambien 10 mg 30 CA FL SH

02/10/06 1037832 Ambien 10 mg 30 NC OH SH

02/11/06 1038126 Ambien 10 mg 30 TX OH SH


(7) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: acetaminophen/codeine 300/30.


PtState

PresState RPh

10/26/05 1014456 APAP/codeine 300/30 mg 90 WA GA SH

10/27/05 1014509 APAP/codeine 300/30 mg 60 RI FL MBH

11/14/05 1018436 APAP/codeine 300/30 mg 60 IL FL SH

11/21/05 1020122 APAP/codeine 300/30 mg 60 NY OH SH

11/25/05 1020809 APAP/codeine 300/30 mg 90 IN OH SH

11/26/05 1021177 APAP/codeine 300/30 mg 90 WA GA SH

11/28/05 1021393 APAP/codeine 300/30 mg 90 VA OH SH

12/06/05 1023202 APAP/codeine 300/30 mg 90 VA FL SH

12/19/05 1025546 APAP/codeine 300/30 mg 60 IL FL SH

12/20/05 1025849 APAP/codeine 300/30 mg 90 MA OH MBH

12/23/05 1026764 APAP/codeine 300/30 mg 90 TX FL SH12/30/05 1028107 APAP/codeine 300/30 mg 90 IN OH SH

01/10/06 1030269 APAP/codeine 300/30 mg 90 MD FL SH


01/13/06 1031274 APAP/codeine 300/30 mg 90 UT FL SH

01/24/06 1033618 APAP/codeine 300/30 mg 90 TN FL SH

01/25/06 1033898 APAP/codeine 300/30 mg 60 CA FL SH

02/01/06 1035168 APAP/codeine 300/30 mg 90 OH FL SH

02/03/06 1035963 APAP/codeine 300/30 mg 90 CA OH BB

02/06/06 1036528 APAP/codeine 300/30 mg 90 NJ FL SH

02/08/06 1037035 APAP/codeine 300/30 mg 90 NY OH BB

8/6/2019 Mins 08040709

22/195


PtState

PresState RPh



(8) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct was

not in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: butalbital/aspirin/caffeine/codeine 30 mg.


PtState

PresState RPh

10/19/05 1013071 But/Asa/Caff/Cod 30 mg 90 OK OH SH

10/20/05 1013250 But/Asa/Caff/Cod 30 mg 90 FL FL SH

10/20/05 1013292 But/Asa/Caff/Cod 30 mg 90 IL OH SH

10/20/05 1013410 But/Asa/Caff/Cod 30 mg 60 MI FL SH

10/21/05 1013443 But/Asa/Caff/Cod 30 mg 90 VA OH SH

10/26/05 1014441 But/Asa/Caff/Cod 30 mg 30 FL FL SH10/27/05 1014796 But/Asa/Caff/Cod 30 mg 60 MT FL SH

10/28/05 1014936 But/Asa/Caff/Cod 30 mg 90 OH GA SH


11/05/05 1016542 But/Asa/Caff/Cod 30 mg 60 MD FL SH

11/08/05 1017120 But/Asa/Caff/Cod 30 mg 60 GA FL SH

11/09/05 1017422 But/Asa/Caff/Cod 30 mg 90 AZ OH SH

11/10/05 1017706 But/Asa/Caff/Cod 30 mg 60 CA OH SH

11/12/05 1018126 But/Asa/Caff/Cod 30 mg 60 IL FL SH


11/16/05 1018839 But/Asa/Caff/Cod 30 mg 90 OK OH SH

11/17/05 1019062 But/Asa/Caff/Cod 30 mg 90 IL OH SH

11/18/05 1019525 But/Asa/Caff/Cod 30 mg 90 MI OH SH11/19/05 1019782 But/Asa/Caff/Cod 30 mg 60 CA OH SH

11/22/05 1020436 But/Asa/Caff/Cod 30 mg 90 VA OH SH



11/30/05 1022094 But/Asa/Caff/Cod 30 mg 90 TX GA SH

12/06/05 1023018 But/Asa/Caff/Cod 30 mg 90 CO GA MBH

12/06/05 1023196 But/Asa/Caff/Cod 30 mg 90 CO OH SH

12/09/05 1023864 But/Asa/Caff/Cod 30 mg 60 OH OH SH

12/14/05 1024638 But/Asa/Caff/Cod 30 mg 60 IL FL SH

12/19/05 1025716 But/Asa/Caff/Cod 30 mg 90 CA FL SH

12/19/05 1025735 But/Asa/Caff/Cod 30 mg 90 NY OH SH

12/20/05 1026092 But/Asa/Caff/Cod 30 mg 60 ME FL SH12/20/05 1026020 But/Asa/Caff/Cod 30 mg 60 MI FL SH




12/28/05 1027487 But/Asa/Caff/Cod 30 mg 90 WA GA SH


01/07/06 1029664 But/Asa/Caff/Cod 30 mg 60 WA FL SH


02/01/06 1035124 But/Asa/Caff/Cod 30 mg 60 ID OH SH

02/03/06 1035765 But/Asa/Caff/Cod 30 mg 90 CA FL BB

8/6/2019 Mins 08040709

23/195

8/6/2019 Mins 08040709

24/195


PtState

PresState RPh

10/27/05 1014508 diazepam 10 mg 90 TN FL MBH

10/31/05 1014709 diazepam 10 mg 30 TN GA SH

10/31/05 1015393 diazepam 10 mg 90 AL FL SH

10/31/05 1015234 diazepam 10 mg 90 TN OH SH

11/01/05 1015237 diazepam 10 mg 60 VA OH SH

11/01/05 1015657 diazepam 10 mg 60 FL GA SH

11/02/05 1015678 diazepam 10 mg 90 WA OH SH

11/05/05 1015839 diazepam 10 mg 30 AK GA SH

11/07/05 1016576 diazepam 10 mg 90 MS GA SH

11/08/05 1016704 diazepam 10 mg 30 CA FL SH

11/09/05 1016974 diazepam 10 mg 30 CA GA SH

11/09/05 1017216 diazepam 10 mg 90 CT FL SH

11/09/05 1017248 diazepam 10 mg 60 FL GA SH

11/09/05 1017333 diazepam 10 mg 60 GA FL SH

11/09/05 1017264 diazepam 10 mg 90 MI FL SH

11/10/05 1017468 diazepam 10 mg 30 TX FL SH


11/12/05 1017640 diazepam 10 mg 90 VA FL SH


11/14/05 1018092 diazepam 10 mg 90 WV FL SH

11/15/05 1018398 diazepam 10 mg 60 NM FL SH


11/16/05 1018815 diazepam 10 mg 60 LA FL SH

11/16/05 1019004 diazepam 10 mg 60 NC FL SH

11/16/05 1018818 diazepam 10 mg 60 SC FL SH

11/17/05 1018918 diazepam 10 mg 60 TN FL SH


11/17/05 1019326 diazepam 10 mg 60 PA FL SH

11/18/05 1019158 diazepam 10 mg 30 TX OH SH

11/18/05 1019377 diazepam 10 mg 60 CO GA SH

11/19/05 1019508 diazepam 10 mg 60 SC FL MBH


11/25/05 1020127 diazepam 10 mg 60 AZ OH SH

11/25/05 1020883 diazepam 10 mg 60 GA GA SH

11/25/05 1020879 diazepam 10 mg 30 LA GA SH

11/25/05 1020907 diazepam 10 mg 30 MA OH SH


11/25/05 1020936 diazepam 10 mg 90 NY OH SH

11/25/05 1020848 diazepam 10 mg 90 OH FL SH


11/26/05 1021132 diazepam 10 mg 60 AZ FL SH

11/28/05 1021152 diazepam 10 mg 60 NJ GA SH


11/29/05 1021634 diazepam 10 mg 60 IL FL SH


11/29/05 1021936 diazepam 10 mg 90 CA OH SH





12/06/05 1022984 diazepam 10 mg 60 AL FL MBH

12/07/05 1023134 diazepam 10 mg 60 MA FL SH

8/6/2019 Mins 08040709

25/195


PtState

PresState RPh

12/09/05 1023297 diazepam 10 mg 60 MN GA SH

12/09/05 1023849 diazepam 10 mg 90 FL FL SH




12/13/05 1023976 diazepam 10 mg 60 MS FL SH

12/13/05 1024319 diazepam 10 mg 90 NY FL MBH

12/14/05 1024458 diazepam 10 mg 60 WV FL SH

12/14/05 1024582 diazepam 10 mg 30 NJ OH SH

12/14/05 1024547 diazepam 10 mg 30 WA GA SH

12/15/05 1024604 diazepam 10 mg 90 WI FL SH





12/16/05 1025269 diazepam 10 mg 90 HI FL SH

12/16/05 1025074 diazepam 10 mg 60 SC FL SH

12/19/05 1025148 diazepam 10 mg 30 WA FL SH


12/19/05 1025658 diazepam 10 mg 30 MI OH SH








12/22/05 1026374 diazepam 10 mg 90 MS GA SH

12/22/05 1026597 diazepam 10 mg 60 CO GA SH

12/22/05 1026665 diazepam 10 mg 90 OH OH SH


12/27/05 1026872 diazepam 10 mg 60 AZ OH SH





12/29/05 1027735 diazepam 10 mg 60 AL OH SH

12/29/05 1027794 diazepam 10 mg 60 AZ GA SH

12/29/05 1027869 diazepam 10 mg 90 NJ FL SH

12/30/05 1027909 diazepam 10 mg 60 PA FL SH

01/07/06 1028080 diazepam 10 mg 90 AL FL SH




01/09/06 1030021 diazepam 10 mg 60 NJ GA SH

01/09/06 1030063 diazepam 10 mg 60 OH OH SH







8/6/2019 Mins 08040709

26/195

8/6/2019 Mins 08040709

27/195


PtState

PresState RPh

02/06/06 1036357 diazepam 10 mg 30 NY FL SH



02/08/06 1037124 diazepam 10 mg 60 NJ OH BB

02/09/06 1037116 diazepam 10 mg 60 TN OH BB


02/10/06 1037704 diazepam 10 mg 30 CA GA SH

02/10/06 1037584 diazepam 10 mg 60 NC OH SH

02/10/06 1037883 diazepam 10 mg 60 NJ FL SH





prescriptions pursuant to internet sales without a valid physician-patientrelationship: diazepam 5 mg.


PtState

PresState RPh






11/25/05 1020932 diazepam 5 mg 60 IL GA SH


11/30/05 1022031 diazepam 5 mg 30 WI GA SH12/19/05 1025491 diazepam 5 mg 30 WA OH SH



01/10/06 1030472 diazepam 5 mg 60 MA GA SH

01/11/06 1030789 diazepam 5 mg 60 OR FL SH

01/17/06 1031914 diazepam 5 mg 90 WI FL SH




02/03/06 1035807 diazepam 5 mg 60 FL FL BB

02/03/06 1036010 diazepam 5 mg 30 VA FL BB

02/06/06 1036355 diazepam 5 mg 30 CA FL SH02/06/06 1036384 diazepam 5 mg 60 VA FL SH

02/09/06 1037379 diazepam 5 mg 90 MA FL SH

02/11/06 1038118 diazepam 5 mg 60 OR FL SH



8/6/2019 Mins 08040709

28/195

prescriptions pursuant to internet sales without a valid physician-patientrelationship: diazepam oral concentrated solution 5 mg/ml.


PtState

PresState RPh

01/10/06 1030460 diazepam 5 mg/ml 90 MA FL SH

02/06/06 1036480 diazepam 5 mg/ml 90 GA GA SH


(13) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: Fioricet/codeine 30 mg.


PtState

PresState RPh

10/21/05 1013698 Fioricet/Cod 30 mg 60 FL FL SH

11/18/05 1019391 Fioricet/Cod 30 mg 60 CA FL SH

11/26/05 1021162 Fioricet/Cod 30 mg 60 FL GA SH

01/19/06 1032719 Fioricet/Cod 30 mg 60 MI GA SH


(14) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct wasnot in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: hydrocodone/ibuprofen 7.5/200 mg.


PtState

PresState RPh

10/19/05 1013064 hydrocodone/ibu 7.5/200 mg 90 CA OH SH

10/21/05 1013686 hydrocodone/ibu 7.5/200 mg 90 DE FL SH

10/21/05 1013538 hydrocodone/ibu 7.5/200 mg 90 MD GA SH

10/25/05 1014213 hydrocodone/ibu 7.5/200 mg 90 PA FL SH

10/27/05 1014745 hydrocodone/ibu 7.5/200 mg 90 CO OH SH

10/27/05 1014679 hydrocodone/ibu 7.5/200 mg 90 MI OH SH

10/27/05 1014729 hydrocodone/ibu 7.5/200 mg 90 NJ FL SH

10/28/05 1014939 hydrocodone/ibu 7.5/200 mg 90 AZ GA SH

10/28/05 1015041 hydrocodone/ibu 7.5/200 mg 90 NJ FL SH

11/02/05 1015917 hydrocodone/ibu 7.5/200 mg 90 OH OH SH

11/08/05 1016907 hydrocodone/ibu 7.5/200 mg 90 CA GA SH11/09/05 1017230 hydrocodone/ibu 7.5/200 mg 90 IL GA SH

11/10/05 1017643 hydrocodone/ibu 7.5/200 mg 90 FL OH SH

11/10/05 1017795 hydrocodone/ibu 7.5/200 mg 90 FL FL SH

11/10/05 1017538 hydrocodone/ibu 7.5/200 mg 90 TX OH SH

11/11/05 1017968 hydrocodone/ibu 7.5/200 mg 90 NC FL SH




11/15/05 1018538 hydrocodone/ibu 7.5/200 mg 90 CA FL SH

8/6/2019 Mins 08040709

29/195


PtState

PresState RPh

11/16/05 1019039 hydrocodone/ibu 7.5/200 mg 60 MA FL SH


11/21/05 1019987 hydrocodone/ibu 7.5/200 mg 90 GA FL SH


11/25/05 1021066 hydrocodone/ibu 7.5/200 mg 90 AZ GA SH


11/25/05 1020782 hydrocodone/ibu 7.5/200 mg 60 CO FL SH


11/25/05 1020905 hydrocodone/ibu 7.5/200 mg 90 MA OH SH

11/25/05 1021052 hydrocodone/ibu 7.5/200 mg 60 TX GA SH

11/26/05 1021184 hydrocodone/ibu 7.5/200 mg 90 CT FL SH

11/26/05 1021185 hydrocodone/ibu 7.5/200 mg 90 MI OH SH

11/26/05 1021186 hydrocodone/ibu 7.5/200 mg 90 MN FL SH


11/30/05 1022109 hydrocodone/ibu 7.5/200 mg 90 ID FL SH


12/13/05 1024333 hydrocodone/ibu 7.5/200 mg 90 FL FL MBH


12/14/05 1024634 hydrocodone/ibu 7.5/200 mg 90 IN FL SH

12/20/05 1025937 hydrocodone/ibu 7.5/200 mg 90 AZ OH SH



12/21/05 1026132 hydrocodone/ibu 7.5/200 mg 120 SC FL SH

12/21/05 1026342 hydrocodone/ibu 7.5/200 mg 90 TX FL SH





12/27/05 1027148 hydrocodone/ibu 7.5/200 mg 90 MN FL SH

12/28/05 1027630 hydrocodone/ibu 7.5/200 mg 90 AZ FL SH

12/28/05 1027619 hydrocodone/ibu 7.5/200 mg 90 UT FL SH



01/05/06 1029031 hydrocodone/ibu 7.5/200 mg 90 IL FL SH

01/05/06 1029034 hydrocodone/ibu 7.5/200 mg 90 TX OH SH

01/07/06 1029608 hydrocodone/ibu 7.5/200 mg 90 MI FL SH


01/07/06 1029460 hydrocodone/ibu 7.5/200 mg 60 VA OH SH



01/09/06 1030072 hydrocodone/ibu 7.5/200 mg 60 AZ FL SH




01/09/06 1030161 hydrocodone/ibu 7.5/200 mg 60 IL OH SH



01/12/06 1031192 hydrocodone/ibu 7.5/200 mg 90 TX GA SH

01/12/06 1031181 hydrocodone/ibu 7.5/200 mg 90 WI FL SH


01/18/06 1032312 hydrocodone/ibu 7.5/200 mg 90 AZ OH SH


8/6/2019 Mins 08040709

30/195


PtState

PresState RPh


01/21/06 1033184 hydrocodone/ibu 7.5/200 mg 120 MA OH SH

01/24/06 1033636 hydrocodone/ibu 7.5/200 mg 90 NJ GA SH

01/25/06 1033847 hydrocodone/ibu 7.5/200 mg 90 NY OH SH

01/26/06 1034183 hydrocodone/ibu 7.5/200 mg 120 LA FL SH

01/26/06 1034147 hydrocodone/ibu 7.5/200 mg 90 TX FL SH

01/31/06 1034963 hydrocodone/ibu 7.5/200 mg 90 NC OH SH


02/01/06 1035258 hydrocodone/ibu 7.5/200 mg 120 OH GA SH





02/06/06 1036303 hydrocodone/ibu 7.5/200 mg 90 MI FL SH

02/06/06 1036288 hydrocodone/ibu 7.5/200 mg 60 OK FL SH

02/06/06 1036467 hydrocodone/ibu 7.5/200 mg 90 OK FL SH






02/10/06 1038010 hydrocodone/ibu 7.5/200 mg 90 NC FL SH


02/11/06 1038110 hydrocodone/ibu 7.5/200 mg 90 VA OH SH



(15) Steven Holtel did, from October 17, 2005, through February 14, 2006,knowingly sell or offer to sell a controlled substance when the conduct was

not in accordance with Chapters 3719., 4729., and 4731. of the OhioRevised Code, to wit: Steven Holtel admittedly sold the followingprescriptions pursuant to internet sales without a valid physician-patientrelationship: hydrocodone/acetaminophen 10/325 mg.


PtState

PresState RPh

10/19/05 1012991 hydrocodone/APAP 10/325 mg 90 UT FL SH

10/19/05 1012998 hydrocodone/APAP 10/325 mg 90 IL FL SH

10/19/05 1013019 hydrocodone/APAP 10/325 mg 90 OK OH SH

10/19/05 1013081 hydrocodone/APAP 10/325 mg 90 WA FL SH

10/19/05 1013104 hydrocodone/APAP 10/325 mg 120 CA OH SH

10/19/05 1013111 hydrocodone/APAP 10/325 mg 90 TX FL SH10/19/05 1013119 hydrocodone/APAP 10/325 mg 90 TX FL SH

10/19/05 1013120 hydrocodone/APAP 10/325 mg 90 MA FL SH

10/19/05 1013122 hydrocodone/APAP 10/325 mg 90 MA OH SH

10/19/05 1013123 hydrocodone/APAP 10/325 mg 60 CA FL SH

10/19/05 1013126 hydrocodone/APAP 10/325 mg 90 TX GA SH

10/19/05 1013128 hydrocodone/APAP 10/325 mg 90 TX NULL SH


10/19/05 1013143 hydrocodone/APAP 10/325 mg 90 GA FL SH


10/19/05 1013146 hydrocodone/APAP 10/325 mg 90 OH FL SH

8/6/2019 Mins 08040709

31/195


PtState

PresState RPh


10/19/05 1013153 hydrocodone/APAP 10/325 mg 90 OR FL SH

10/19/05 1013154 hydrocodone/APAP 10/325 mg 120 CA GA SH

10/19/05 1013155 hydrocodone/APAP 10/325 mg 60 MI FL SH


10/19/05 1013158 hydrocodone/APAP 10/325 mg 90 TX FL SH



10/20/05 1013232 hydrocodone/APAP 10/325 mg 90 FL FL SH

10/20/05 1013272 hydrocodone/APAP 10/325 mg 60 NJ FL SH

10/20/05 1013277 hydrocodone/APAP 10/325 mg 90 NC FL SH


10/20/05 1013283 hydrocodone/APAP 10/325 mg 90 NY OH SH


10/20/05 1013299 hydrocodone/APAP 10/325 mg 120 ID FL SH

10/20/05 1013309 hydrocodone/APAP 10/325 mg 60 CT OH SH


10/20/05 1013313 hydrocodone/APAP 10/325 mg 60 VA FL SH




10/20/05 1013317 hydrocodone/APAP 10/325 mg 90 TN FL SH



10/20/05 1013322 hydrocodone/APAP 10/325 mg 90 IL GA SH

10/20/05 1013344 hydrocodone/APAP 10/325 mg 60 TN OH SH

10/20/05 1013346 hydrocodone/APAP 10/325 mg 90 MN GA SH


10/20/05 1013348 hydrocodone/APAP 10/325 mg 120 SC OH SH

10/20/05 1013349 hydrocodone/APAP 10/325 mg 120 VT GA SH



10/20/05 1013356 hydrocodone/APAP 10/325 mg 60 MD OH SH

10/20/05 1013357 hydrocodone/APAP 10/325 mg 90 FL GA SH


10/20/05 1013386 hydrocodone/APAP 10/325 mg 60 MD FL SH

10/20/05 1013390 hydrocodone/APAP 10/325 mg 90 FL OH SH



10/20/05 1013402 hydrocodone/APAP 10/325 mg 90 MN FL SH


10/20/05 1013404 hydrocodone/APAP 10/325 mg 90 NY GA SH



10/20/05 1013413 hydrocodone/APAP 10/325 mg 90 NY FL SH


10/20/05 1013416 hydrocodone/APAP 10/325 mg 90 MS GA SH

10/20/05 1013419 hydrocodone/APAP 10/325 mg 90 RI FL SH



10/21/05 1013537 hydrocodone/APAP 10/325 mg 90 TX OH SH

10/21/05 1013542 hydrocodone/APAP 10/325 mg 90 TN OH SH

8/6/2019 Mins 08040709

32/195

8/6/2019 Mins 08040709

33/195


PtState

PresState RPh

10/25/05 1014193 hydrocodone/APAP 10/325 mg 90 WA GA SH


10/25/05 1014196 hydrocodone/APAP 10/325 mg 90 ID GA SH

10/25/05 1014200 hydrocodone/APAP 10/325 mg 90 GA OH SH


10/25/05 1014203 hydrocodone/APAP 10/325 mg 90 LA OH SH

10/25/05 1014206 hydrocodone/APAP 10/325 mg 60 NY FL SH


10/25/05 1014214 hydrocodone/APAP 10/325 mg 90 CO FL SH

10/25/05 1014216 hydrocodone/APAP 10/325 mg 60 MD OH SH

10/25/05 1014219 hydrocodone/APAP 10/325 mg 90 NC OH SH



10/25/05 1014225 hydrocodone/APAP 10/325 mg 60 NJ OH SH

10/25/05 1014229 hydrocodone/APAP 10/325 mg 120 OR GA SH

10/26/05 1014235 hydrocodone/APAP 10/325 mg 90 IN FL SH



10/26/05 1014249 hydrocodone/APAP 10/325 mg 120 AL FL SH











10/26/05 1014382 hydrocodone/APAP 10/325 mg 60 HI FL SH

10/26/05 1014394 hydrocodone/APAP 10/325 mg 90 NULL OH SH

10/26/05 1014422 hydrocodone/APAP 10/325 mg 90 VA GA SH


10/26/05 1014444 hydrocodone/APAP 10/325 mg 60 AZ FL SH


10/26/05 1014449 hydrocodone/APAP 10/325 mg 90 IN OH SH

10/26/05 1014462 hydrocodone/APAP 10/325 mg 90 IA OH SH

10/26/05 1014463 hydrocodone/APAP 10/325 mg 90 OK OH SH





10/26/05 1014491 hydrocodone/APAP 10/325 mg 90 MS FL SH









10/27/05 1014667 hydrocodone/APAP 10/325 mg 90 PA FL SH

8/6/2019 Mins 08040709

34/195


PtState

PresState RPh


10/27/05 1014670 hydrocodone/APAP 10/325 mg 90 WA OH SH



10/27/05 1014677 hydrocodone/APAP 10/325 mg 90 WI GA SH







10/27/05 1014732 hydrocodone/APAP 10/325 mg 120 NY OH SH



10/27/05 1014741 hydrocodone/APAP 10/325 mg 90 NJ GA SH

10/27/05 1014743 hydrocodone/APAP 10/325 mg 60 AL GA SH

10/27/05 1014750 hydrocodone/APAP 10/325 mg 90 OH OH SH


10/27/05 1014756 hydrocodone/APAP 10/325 mg 90 MS GA SH



10/27/05 1014768 hydrocodone/APAP 10/325 mg 60 WY OH SH





10/27/05 1014781 hydrocodone/APAP 10/325 mg 90 TN GA SH











10/28/05 1015013 hydrocodone/APAP 10/325 mg 90 MS FL SH

10/28/05 1015017 hydrocodone/APAP 10/325 mg 60 MI OH SH



10/28/05 1015033 hydrocodone/APAP 10/325 mg 120 AZ FL SH




10/29/05 1015051 hydrocodone/APAP 10/325 mg 90 CT GA SH

10/29/05 1015081 hydrocodone/APAP 10/325 mg 90 AZ GA SH


10/31/05 1015184 hydrocodone/APAP 10/325 mg 90 LA FL SH

10/31/05 1015205 hydrocodone/APAP 10/325 mg 90 OK GA SH


10/31/05 1015236 hydrocodone/APAP 10/325 mg 90 VA OH SH

8/6/2019 Mins 08040709

35/195


PtState

PresState RPh







10/31/05 1015303 hydrocodone/APAP 10/325 mg 90 IL OH SH





10/31/05 1015373 hydrocodone/APAP 10/325 mg 120 WI GA SH





10/31/05 1015404 hydrocodone/APAP 10/325 mg 90 ID OH SH







11/01/05 1015648 hydrocodone/APAP 10/325 mg 90 MS OH SH







11/01/05 1015666 hydrocodone/APAP 10/325 mg 90 AL GA SH






11/01/05 1015692 hydrocodone/APAP 10/325 mg 120 WI FL SH

11/01/05 1015693 hydrocodone/APAP 10/325 mg 90 SC FL SH

11/01/05 1015696 hydrocodone/APAP 10/325 mg 90 MA GA SH



11/02/05 1015823 hydrocodone/APAP 10/325 mg 90 MN OH SH








11/02/05 1015848 hydrocodone/APAP 10/325 mg 90 OR OH SH

11/02/05 1015858 hydrocodone/APAP 10/325 mg 90 IN GA SH


8/6/2019 Mins 08040709

36/195


PtState

PresState RPh


11/02/05 1015888 hydrocodone/APAP 10/325 mg 90 MI GA SH



11/02/05 1015893 hydrocodone/APAP 10/325 mg 90 PA OH SH


11/02/05 1015895 hydrocodone/APAP 10/325 mg 90 MA GA SH






11/02/05 1015937 hydrocodone/APAP 10/325 mg 60 OK GA SH



11/04/05 1016224 hydrocodone/APAP 10/325 mg 90 PA GA SH










11/04/05 1016258 hydrocodone/APAP 10/325 mg 90 SC FL SH


11/04/05 1016264 hydrocodone/APAP 10/325 mg 90 LA FL SH



11/04/05 1016289 hydrocodone/APAP 10/325 mg 90 NULL FL SH





11/04/05 1016359 hydrocodone/APAP 10/325 mg 120 MN OH SH






11/04/05 101

Documents

Mins 08040709